1888 – 1971

Royal Raymond Rife

He built unusual microscopes and reported seeing filterable organisms that other researchers could not reproduce. Later accounts attributed disease-treatment claims to his frequency instruments. This guide separates surviving records from the legend.

PRIMARY ARCHIVE

Evidence Vault

  • Smithsonian Annual Report (1944)
  • Congressional Record — Fitzgerald Report (1953)
  • San Diego Tribune & LA Times coverage (1931–1938)
  • Beam Ray trial transcripts (1939)
Explore sources

Universal Microscope

5,682 parts

Documented in 1944

Clinical Trial

Summer 1934

USC committee

Beam Ray

3–4.6 MHz

RF carrier

Surviving Unit

Microscope No. 5

Science Museum, London

What the surviving record documents

Primary sources from the Smithsonian, Congressional Record, and contemporary newspapers.

Smithsonian • 1944

Universal Microscope

A 1944 publication reported the instrument's construction and Rife's extraordinary optical claims

San Diego Tribune • 1938

Front Page News

"Dread Disease Germs Killed by Radio Waves"

Congress • 1953

Fitzgerald Report

An investigator alleged obstruction of purported cancer treatments; the report did not validate Rife therapy

Science Museum • Present

Surviving Microscope

Microscope No. 5 preserved in London (Inv. 1990-667)

MODERN THERAPIES — IMPORTANTLY DISTINCT

FDA-authorized electromagnetic therapies show that electric fields can have specific biological effects. They do not validate Rife's microscope, MORs, frequency lists, or devices.

TTFields
Tumor Treating Fields

FDA-approved for glioblastoma. 100-300 kHz frequencies.

2024
TheraBionic HDE

FDA humanitarian exemption in 2023 for a narrow advanced-liver-cancer indication.

44%
Preprint Result

44% in-vitro leukemia-cell inhibition; not a clinical validation of Rife therapy.

"I have ended up a pauper, but I achieved the impossible."
— Royal Raymond Rife, 1960 affidavit